CAPTIVATE
"CAPTIVATE" is a word mark owned by Ipsen Biopharm Limited, filed at the USPTO on September 30, 2026. It is under examination and covers classes 1, 3, 5, 10, 41 and 44.
- Status
- Under examination
- Since September 30, 2026
- Filed
- September 30, 2026
- Registered
- Not yet
- Priority date
- September 29, 2026
- Claimed from United Kingdom
- Application no.
- 50138781
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 6 classes
Who owns CAPTIVATE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Ipsen Biopharm Limited
Wrexham, United Kingdom
Representative
Makiko Coffland
Christensen O'Connor Johnson Kindness
What the mark covers
The products and services CAPTIVATE is filed for, grouped by Nice class.
Chemical additives for use in the manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of pharmaceuticals; Biological preparations for use in industry and science
Cosmetic preparations; Cosmetics sold as an integral component of non-medicated skincare preparations
Pharmaceutical preparations for the treatment and prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; Pharmaceutical preparations for the treatment and prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Diagnostic substances for medical use
Medical apparatus for use in treating cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical apparatus for use in treating gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical devices for use in treating or diagnosing cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders; Medical devices for use in treating or diagnosing gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain, glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin
Providing information about education; Arranging and conducting of seminars and workshops in the field of science, health, medicine, pharmacy and beauty; Publishing e-books in the field of science, health, medicine, pharmacy and beauty; Providing online non-downloadable journals in the field of science, health, medicine, pharmacy and beauty; Publishing and issuing scientific papers in relation to medical technology; Instruction in the field of cosmetology
Pharmaceutical advice; Pharmaceutical compounding services; Dispensing of pharmaceuticals; Medical services; Healthcare; Providing healthcare information; Providing educational information about healthcare; Internet-based health care information services; Providing medical information; Medical and pharmaceutical consultation; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing news and information in the field of medicine
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About CAPTIVATE
Who owns the trademark "CAPTIVATE"?
The USPTO trademark "CAPTIVATE" (application 50138781) is owned by Ipsen Biopharm Limited.
What is the status of "CAPTIVATE"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull CAPTIVATE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0fa30-f9d2-7438-b347-f9184a6d3984
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0fa30-f9d2-7438-b347-f9184a6d3984",
"object": "trademark",
"mark_text": "CAPTIVATE",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50138781",
"filing_date": "2026-09-30",
"nice_classes": [
1,
3,
5,
10,
41,
44
],
"owners": [
{
"name": "Ipsen Biopharm Limited",
"entity_id": "ent_019eb708-e440-75d9-a932-4d18c18228d2"
}
]
}